Laser focused
In today’s top story, Real Deals catches up with Francesco Orsi, managing director, Eurazeo.
The discussion comes after the GP sold Dutch Ophthalmic Research Center (DORC) for €1bn.
Interestingly, Eurazeo acquired the business just before the Covid pandemic and therefore it was negatively affected by the lockdowns.
But, according to Orsi, the GP supported DORC through that difficult period by implementing a focused value creation plan.
Orsi also tells Real Deals that the GP sees complementarities between its portfolio company and the trade buyer: “Zeiss has a very limited presence when it comes to retina surgery, which is a strong suit of DORC.”
Read our top story below to find out more about how Eurazeo got the company in good shape to be sold.
Xhulio Ismalaj
Reporter
xhulio.ismalaj@realdealsmedia.com